Robotic bronchoscopy can help diagnose spots in the lungs when they are still small, catching cancer sooner and saving many ...
The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
5d
Zacks.com on MSNInsmed's NDA for Lung Disease Drug Gets FDA's Priority ReviewInsmed Incorporated INSM announced that the FDA has accepted its new drug application (“NDA”) seeking approval of its reversible inhibitor of dipeptidyl peptidase 1 (DPP1), brensocatib, for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results